Valery Feigin, MD, MSc, PhD, FAAN

10507Current Position:

Professor of Epidemiology and Neurology, Director of the National Institute for Stroke and Applied Neurosciences (NISAN), School of Public Health and Psychosocial Studies, Faculty of Health and Environmental Sciences, AUT University, Auckland, New Zealand.

SCOPUS Citation Output: (h-index 56, number of citations 42,000) as of December 2018

Twitter: @FeiginValery

With over 910,000 downloads of his papers (ScienceDirect, December 2018) that have been cited by over 69,600 times (according to Google Scholar) and >42,000 times (by Scopus), Valery’s papers are currently ranked by ScienceDirect in the top 1% by citations. He is the number one scientist in NZ by the number of citations (citation impact factor >110).

Medical and Research Background:

Valery is a certified neurologist and clinical epidemiologist. He graduated in medicine from the State Medical School of Novosibirsk, Russia and undertook advanced training in neurology and clinical epidemiology (Institute of Neurology, Moscow, Russia - PhD; Mayo Clinic, Rochester, MN, USA and Erasmus University, Rotterdam, the Netherlands - Master of Science in Clinical Epidemiology).

Research Projects:

Valery has contributed to the design and performance of a number of national and international research projects  including:

  • RIBURST study (Reducing the International Burden of Stroke using Mobile Technology)
  • MARS study (Effectiveness of the Stroke Riskometer Pro App / Mobile Apps to Reduce Stroke)
  • The WHO MONICA project
  • Freemasons Health study
  • Auckland Regional Community Stroke (ARCOS) study
  • Traumatic brain injury burden in New Zealand: A population-based incidence & outcomes study (BIONIC and BIONIC4You studies)
  • The Neuroprotection Involving Cooling Evaluation in Stroke study (NICE)
  • Asian Pacific Cohort Studies Collaboration (APCSC)
  • POLYPILL Recruitment pilot study
  • Auckland Stroke Outcomes (ASTRO) study
  • Stroke Attention Rehabilitation Trial (START)
  • Goals and Self Regulation Skills in Brain Injury Rehabilitation
  • POLYPILL IMPACT (Improving Adherence using Combination Therapy) trial projects
  • Disabled by Illness or Injury Study: Does it Matter? study

Journal Editor and Editorial Board member:

  • 2008-present - Editor-in-Chief of Neuroepidemiology
  • 2018-present - Journal of Stroke Medicine
  • 2014-present - American Journal of Trauma and Treatment
  • 2014-present - Neurology, Neuropsychiatry, Psychosomatics
  • 2013-present - Honorary Editorial Board of the Journal of Neurorestoratology
  • 2012-present - Cerebrovascular Disease
  • 2012-2018     - European Medical Journal - Neurology
  • 2011-present - World Journal of Methodology
  • 2011-present - World Journal of Neurology
  • 2011-present - Journal of Geriatric Cardiology
  • 2010-present - Topics in Stroke Rehabilitation
  • 2009-present - Stroke Research and Treatment
  • 2007-2008 - Stroke
  • 2005-present - Acta Clinica Croatica
  • 2005-present - Actualizaciones en neurologia, neurociencias y envejejecimiento
  • 2002-present - Updates in Neurology, Neuroscience and Aging
  • 1999-present - European Journal of Neurology
  • 1997-2002 - The Pain and its treatment

Membership in Professional Societies and other activities:

Valery is a member of numerous professional societies and committees, including:

  • 2018-present: Executive Committee member - World Stroke Organization
  • 2017 - present: International Advisory Board member, International Institute for Brain Health, Croatia
  • 2015 - National Science Challenge - Ageing Well Science Leadership Team
  • 2014 - Brain Research New Zealand, Centre of Research Excellence (CoRE), Ministry of Business, Innovation & Employment
  • Founding member of the Scientist Panel on Neuroepidemiology
  • Task Force on Teaching of Clinical Epidemiology of the European Federation of Neurological Societies
  • Faculty member of Educational Activities in Eastern Europe of the European Federation of Neurological Societies
  • 2011-present - World Stroke Organization (Board of Directors 2012-2016)
  • 2013-present – World Stroke Organization Stroke Guidelines and Quality Committee
  • 2010-present - INTERSTROKE Study, Steering Committee member
  • 2010-present - Neurology Association of New Zealand
  • 2010-present - Northern Region Stroke Network
  • 2009-present - American Academy of Neurology, Neuroepidemiology section
  • 2007-2009 - World Federation for NeuroRehabilitation, Management Committee member
  • 2006-2008 - World Stroke Organization, Chair of the Membership Committee
  • 2002-present - Stroke Society of Australasia, Fellow
  • 1998-2000 - European Neurological Society, Fellow
  • 1997- present - American Academy of Neurology, Fellow
  • 1996-2005 - European Federation of Neurological Societies, Chair of the Task Force
  • 1997-1999 - European Society for Clinical Neuropharmacology, Advisory Board member
  • 1995-present - Mayo Alumni Association, Fellow
  • 1992-2002 - Stroke Council of the American Heart Association, Fellow
  • 1989-2006 - International Stroke Society, Fellow

Publications, Awards, Honours:

Valery has authored and/or co-authored:

  • More than 600 scientific publications on stroke epidemiology, prevention and management, including 12 handbooks
  • A number of book chapters and Cochrane systematic reviews
  • Guidelines for physicians, including more than 46 papers in The Lancet and Lancet Neurology

Valery is the recipient of a number of prestigious national and international awards and distinctions, including:

  • The Royal Society of New Zealand’s MacDiarmid Medal, for outstanding research in stroke epidemiology and prevention worldwide, and the development of ground-breaking technology in primary stroke prevention
  • The World Stroke Organization President’s Award for Contributions to Clinical Stroke Research
  • Fogarty International Centre Research Grant Award (National Institute of Neurological Disorders & Stroke of the USA, Mayo Clinic, MN, USA)
  • Bruce Shoenburg International Award and Lecture in Neuroepidemiology (American Academy of Neurology) Gedeon Richter Award for Studies on Cavinton in Acute Stroke
  • Honorary Professor (Novosibirsk State Medical Academy)
  • Professor of Neurology (Russian Academy of Medical Sciences)
  • Affiliate Professor, Department of Global Health, University of Washington, USA

Research Interests:

  • Cerebrovascular disorders (incidence, prevalence, risk factors, outcomes, prognosis, treatment, rehabilitation, health care organisation), dementia (incidence, prevalence, determinants, prevention and management)
  • Traumatic brain injury (incidence, prevalence, prevention, rehabilitation and health care organisation)
  • Clinical epidemiology (especially surveys, case-control studies, cohort studies and randomised controlled clinical trials)
  • Public health (especially in relation to neurological disorders and traumatic brain injury) and neuropsychology

Areas of particular expertise are:

  • Stroke and Traumatic Brain Injury prevention
  • Epidemiology and treatment/rehabilitation
  • Neuroepidemiology


As well as attending and presenting at numerous conferences, Valery is Chairman and Founder of:

  • The International Congress on Clinical Neurology and Epidemiology (ICNE)
  • The New Zealand Applied Neurosciences Conference (NZANC)

Publications: (Current year and immediately preceding year only)


Feigin, V.L. et. al. (CENTER-TBI Investigators and Participants) (2019). Variation in neurosurgical management of traumatic brain injury: A survey in 68 centers participating in the CENTER-TBI study. Acta Neurochirurgica. doi:10.1007/s00701-018-3761-z

Feigin, V.L., et. al. (2019). The International comparison of Systems of care and patient outcomes In minor Stroke and Tia (InSIST) study: A community-based cohort study. International Journal of Stroke, doi:10.1177/1747493018799983

Krishnamurthi, R., Hale, L., Barker-Collo, S., Theadom, A., Bhattacharjee, R., George, A., Parmar, P., . . . Feigin, V. (2018). Mobile technology for primary stroke prevention. Stroke, 50, 196-198. doi:10.1161/STROKEAHA.118.023058


Theadom, A., Barker-Collo, S., Jones, K., Dudley, M., Vincent, N., & Feigin, V. (2018). A pilot randomized controlled trial of on-line interventions to improve sleep quality in adults after mild or moderate traumatic brain injury. Clinical Rehabilitation, 32(5). doi:10.1177/0269215517736671

Mahon, S., Krishnamurthi, R., Vandal, A., Witt, E., Barker-Collo, S., Parmar, P., . . . Feigin, V. (2018). Primary prevention of stroke and cardiovascular disease in the community (PREVENTS): Methodology of a health wellness coaching intervention to reduce stroke and cardiovascular disease risk, a randomized clinical trial. International Journal of Stroke, 13(2). doi:10.1177/1747493017730759

Feigin, V.L., Parmar, P., Krishnamurthi, R. et. al. (GBD 2016 Lifetime Risk of Stroke Collaborators) (2018). Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. New England Journal of Medicine, 379(25), 2429-2437. doi:10.1056/NEJMoa1804492

Kasabov, N., Doborjeh, M., Merkin, A., & Feigin, V. (2018). Brain-Inspired AI for personalised predictive modelling of neurological diseases. Neuroepidemiology.

Gao, Y., Jiang, B., Sun, H., Ru, X., Sun, D., Wang, L., Jiang, Y., Feigin, V.L., & Wang, Y. (2018).  The burden of stroke in China: Results from a nationwide population-based epidemiological survey. PLoS One, 13(12), e0208398. doi: 10.1371/journal.pone.0208398

Feigin, V., & GBD 2016 Dementia Collaborators. (2018). Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. doi:10.1016/S1474-4422(18)30403-4

Feigin, V., Theadom, A., & GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. (2018). Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. doi:10.1016/S1474-4422(18)30415-0

Feigin, V. L., & Vos, T. (2018). Global burden of neurological disorders: From global burden of disease estimates to actions. Neuroepidemiology, 52(1-2), 1-2. doi:10.1159/000495197

Feigin, V. & GBD 2016 Meningitis Collaborators (2018). Global, regional, and national burden of meningitis, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(12), 1061-1082. doi:10.1016/S1474-4422(18)30387-9

Feigin, V., & GBD 2017 Population and Fertility Collaborators. (2018). Population and fertility by age and sex for 195 countries and territories, 1950–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1995-2051.

Feigin, V., & GBD 2017 SDG Collaborators. (2018). Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 2091-2138.

Feigin, V., & GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1789-1858.

Feigin, V., & GBD 2017 DALYs and HALE Collaborators. (2018). Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1859-1922.

Feigin, V., & GBD 2017 Risk Factors Collaborators. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1923-1994.

Feigin, V., & GBD 2017 Causes of Death Collaborators. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1736-1788.

Feigin, V., & GBD 2017 Mortality Collaborators. (2018). Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1684-1735.

Feigin, V., & GBD 2016 Motor Neuron Disease Collaborators. (2018). Global, regional, and national burden of motor neuron diseases 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. doi:10.1016/S1474-4422(18)30404-6

Stovner, L. J., Nichols, E., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., Feigin V.L.. . . Murray, C. J. L. (2018). Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(11), 954-976. doi:10.1016/S1474-4422(18)30322-3

Barker-Collo, S., Theadom, A., Jones, K., Starkey, N., Kahan, M., & Feigin, V. (2018). Depression and anxiety across the first 4 years after mild traumatic brain injury: Findings from a community-based study. Brain Injury, 1-8. doi:10.1080/02699052.2018.1540797

Medvedev, O. N., Theadom, A., Barker-Collo, S., Feigin, V., & BIONIC Research Group. (2018). Distinguishing between enduring and dynamic concussion symptoms: Applying Generalisability Theory to the Rivermead Post Concussion Symptoms Questionnaire (RPQ). PeerJ, 6, e5676. doi:10.7717/peerj.5676

Feigin, V.L., and the GBD 2016 Parkinson’s Disease Collaborators (2018). Global, regional, and national burden of Parkinson’s disease, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. doi: 10.1016/S1474-4422(18)30295-3

Bergin, P. S., Brockington, A., Jayabal, J., Scott, S., Litchfield, R., Roberts, L., . . . Feigin, V. (2018). EpiNet study of incidence of status epilepticus in Auckland, New Zealand: Methods and preliminary results. Epilepsia. doi:10.1111/epi.14478

Feigin, V., & Global Burden of Disease 2016 Injury Collaborators. (2018). Global mortality from firearms, 1990-2016. JAMA: Journal of the American Medical Association, 320(8), 792-814. doi:10.1001/jama.2018.10060

Jones, K. M., O'Grady, G., Rodrigues, M. J., Ranta, A., Roxburgh, R. H., Love, D. R., . . . Krishnamurthi, R. (2018). Impacts for children living with genetic muscle disorders and their parents - Findings from a population-based study. Journal of Neuromuscular Diseases, 5(3), 341-352. doi:10.3233/JND-170287

Owolabi, M., Johnson, W., Khan, T., Feigin, V., & Operations Committee of the Lancet Neurology on Stroke. (2018). Effectively combating stroke in Low- and Middle-Income Countries: Placing proof in pragmatism—The Lancet Neurology Commission. Journal of Stroke Medicine, 1(1), 65-67. doi:10.1177/2516608518776706

Feigin, V., & GBD 2016 Alcohol Collaborators. (2018). Alcohol use and burden for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet. doi:10.1016/S0140-6736(18)31310-2

Kahan, M., Jones, K. M., Balalla, S., McPherson, K., Stedman, E., & Feigin, V. L. (2018). Return to pre-injury work following mild traumatic brain injury. Brain Impairment, 1-13. doi:10.1017/BrImp.2018.7

Feigin, V. L. (2018). Driving your recovery post stroke. Neuroepidemiology, 51(3-4), 113-114. doi:10.1159/000490634

Feigin, V.L., Norrving, B., Sudlow, C.L.M. & Sacco, R.L. (2018). Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke. doi:

Feigin. V.L. and the ESO ESMINT EAN SAFEurvey on Stroke Collaborators (2018). Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal. doi: 10.1177/2396987318786023

Jones, K. M., Starkey, N. J., Theadom, A., Gheorghe, A., Willix-Payne, D., Prah, P., & Feigin, V. L. (2018). Parent and child ratings of child behaviour following mild traumatic brain injury. Brain Injury, 1-8. doi:10.1080/02699052.2018.1496477

Feigin, V.L. and the Global Burden of Diseases, Injuries and Risk Factors Study Group 2016 (2018). Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016. The Lancet, 391(10136), 2236-2271. doi:10.1016/S0140-6736(18)30994-2

Jones, K. M., Bhattacharjee, R., Krishnamurthi, R., Blanton, S., Barker-Collo, S., Theadom, A., . . . Feigin, V. L. (2018). Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: A randomized controlled pilot study. Clinical Rehabilitation, doi:10.1177/0269215518777565

Feigin, V.L. and the Disease Control Priorities-3 Cardiovascular, Respiratory, and Related Disorders Author Group (2018). Cardiovascular, respiratory and related disorders: key messages from Disease Control Priorities, 3rd edition. The Lancet, 391, 1224-1236. doi:

Mahon, S., Theadom, A., Barker-Collo, S., Taylor, S., Krishnamurthi, R., Jones, K., . . . Feigin, V. (2018). The contribution of vascular risk factors in prevalence of fatigue four years following stroke: Results from a population-based study. Journal of Stroke and Cerebrovascular Diseases. doi:10.1016/j.jstrokecerebrovasdis.2018.03.020

Phan, H. T., Blizzard, C. L., Reeves, M. J., Thrift, A. G., Cadilhac, D. A., Sturm, J., . . . Gall, S. L. (2018). Factors contributing to sex differences in functional outcomes and participation after stroke. Neurology. doi:10.1212/WNL.0000000000005602

Bejot, Y., Reis, J., Giroud, M., & Feigin, V.L. (2018). A review of epidemiological research on stroke and dementia and exposure to air pollution. International Journal of Stroke. doi:  10.1177/1747493018772800

Feigin, V.L. & Global Burden of Cardiovascular Diseases Collaboration (2018). The burden of cardiovascular diseases among US states, 1990-2016. JAMA Cardiology. doi: 10.1001/jamacardio.2018.0385

Jones, K., Barker-Collo, S., Parmar, P., Starkey, N., Theadom, A., Ameratunga, S., & Feigin, V. L. (2018). Trajectories in health recovery in the 12 months following a mild traumatic brain injury in children: Findings from the BIONIC study. Journal of Primary Health Care, 10(1), 81-89. doi:10.1071/HC17038

Starkey, N. J., Jones, K., Case, R., Theadom, A., Barker-Collo, S., & Feigin, V. (2018). Post-concussive symptoms after a mild traumatic brain injury during childhood and adolescence. Brain Injury, 1-10. doi:10.1080/02699052.2018.1439533

Theadom, A., Starkey, N., Barker-Collo, S., Jones, K., Ameratunga, S., & Feigin, V. (2018). Population-based cohort study of the impacts of mild traumatic brain injury in adults four years post-injury. PLoS ONE, 13(1). doi:10.1371/journal.pone.0191655

Theadom, A., Barker-Collo, S., Jones, K. M., Parmar, P., Bhattacharjee, R., & Feigin, V. L. (2018). MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: A pilot randomised clinical trial. European Journal of Neurology. doi:10.1111/ene.13653

Barker-Collo, S., Theadom, A., Starkey, N., Kahan, M., Jones, K., & Feigin, V. (2018). Factor structure of the Rivermead Post-Concussion Symptoms Questionnaire over the first year following mild traumatic brain injury. Brain Injury, 1-6. doi:10.1080/02699052.2018.1429659

Brainin, M., Feigin, V., Martins, S., Matz, K., Roy, J., Sandercock, P., . . . Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. International Journal of Stroke, 1747493018761190. doi:10.1177/1747493018761190